|
 |
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright ©ERS Journals Ltd 2008
Interpretation of treatment changes in 6-minute walk distance in patients with COPD
1 Horten Centre, University of Zurich, Zurich, Switzerland, 2 Dept of Medicine, University at Buffalo, Buffalo, NY, USA, 3 West Park Healthcare Centre, University of Toronto, Toronto, 4 Dept of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada, and 5 Dept of Epidemiology, Italian National Cancer Institute Regina Elena, Rome, Italy.
CORRESPONDENCE: M. A. Puhan, Horten Centre, University Hospital of Zurich, Postfach Nord, CH-8091 Zurich, Switzerland. Fax: 41 12559720. E-mail: milo.puhan{at}usz.ch
Keywords: Chronic obstructive pulmonary disease, exercise test, interpretation, randomised trials, 6-min walk distance
Received: October 24, 2007
Accepted May 19, 2008
There is uncertainty about the interpretation of changes in the 6-min walk distance (6MWD) in chronic obstructive pulmonary disease (COPD) patients and whether the minimal important difference (MID) for this useful outcome measure exists.
Data were used from nine trials enrolling a wide spectrum of COPD patients with 6MWD at baseline and follow-up and used to determine threshold values for important changes in 6MWD using three distribution-based methods. Anchor-based methods to determine a MID were also evaluated.
Data were included of 460 COPD patients with a mean±SD forced expiratory volume in one second (FEV1) of 39.2±14.1% predicted and 6MWD of 361±112 m at baseline. Threshold values for important effects in 6MWD were between 29 and 42 m, respectively, using the empirical rule effect size and the standardised response mean. The threshold value was 35 m (95% confidence interval 30–42 m) based on the standard error of measurement. Correlations of 6MWD with patient-reported anchors were too low to provide meaningful MID estimates.
6-min walk distance should change by
35 m for patients with moderate to severe chronic obstructive pulmonary disease in order to represent an important effect. This corresponds to a 10% change of baseline 6-min walk distance. The low correlations of 6-min walk distance with patient-reported anchors question whether a minimal important difference exists for the 6-min walk distance.
This article has been cited by other articles:
|
|
 |
|
  G. H Markovitz and C. B Cooper Review series: Rehabilitation in non COPD: Mechanisms of exercise limitation and pulmonary rehabilitation for patients with pulmonary fibrosis/restrictive lung disease Chronic Respiratory Disease, February 1, 2010; 7(1): 47 - 60. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Moullec and G. Ninot An integrated programme after pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: effect on emotional and functional dimensions of quality of life Clinical Rehabilitation, February 1, 2010; 24(2): 122 - 136. [Abstract] [PDF]
|
|
|
|
 |
|
 D. U. Jette, M. C. Bourgeois, and R. Buchbinder Pulmonary Rehabilitation Following Acute Exacerbation of Chronic Obstructive Pulmonary Disease Physical Therapy, January 1, 2010; 90(1): 9 - 12. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bourdin, P-R Burgel, P. Chanez, G. Garcia, T. Perez, and N. Roche Recent advances in COPD: pathophysiology, respiratory physiology and clinical aspects, including comorbidities Eur. Respir. Rev., December 1, 2009; 18(114): 198 - 212. [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Dummer, M. J. Epton, J. O. Cowan, J. M. Cook, R. Condliffe, C. E. Landhuis, A. D. Smith, and D. R. Taylor Predicting Corticosteroid Response in Chronic Obstructive Pulmonary Disease Using Exhaled Nitric Oxide Am. J. Respir. Crit. Care Med., November 1, 2009; 180(9): 846 - 852. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Puhan and H. J. Schunemann How to increase the value of randomised trials in COPD research Eur. Respir. J., September 1, 2009; 34(3): 552 - 558. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. H. Sillen, C. M. Speksnijder, R.-M. A. Eterman, P. P. Janssen, S. S. Wagers, E. F. M. Wouters, N. H. M. K. Uszko-Lencer, and M. A. Spruit Effects of Neuromuscular Electrical Stimulation of Muscles of Ambulation in Patients With Chronic Heart Failure or COPD: A Systematic Review of the English-Language Literature Chest, July 1, 2009; 136(1): 44 - 61. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Salzman The 6-Min Walk Test: Clinical and Research Role, Technique, Coding, and Reimbursement Chest, May 1, 2009; 135(5): 1345 - 1352. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |